コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
3 ients with confirmed RT-PCR testing from April to June 2020 were invited to participate in this study for the assessment
4 All eligible subjects who underwent endoscopy (n = 887) were invited to participate in a follow-up study in June-Augu
5 A total of 10,040 women, 30 to 60 years of age, were invited to participate in the study, 9,451 of whom were
6 ymposium were selected as suitable experts in the field and were invited to participate in the Delphi survey, of which 64
7 dents aged 65 years and older in predefined catchment areas were invited to participate in the survey.
8 e randomly sampled, and households in the intervention arms were invited to participate in UBL, consisting of 14 sessions
11 From January to April 2013, 28 African countries were invited to participate in a review of severe acute respi
14 Behcet patients with localized RNFL defects were invited to participate in a prospective evaluation inclu
15 had been discharged from the maternity ward after delivery were invited to participate in the survey.
16 76 children with increased genetic risk for type 1 diabetes were invited to participate in regular follow-ups, including
17 tiple islet autoantibodies (presymptomatic type 1 diabetes) were invited to participate in a program of diabetes educatio
20 weeks and 6 days of gestation, with a live, singleton fetus were invited to participate by the clinical research team.
23 utive patients undergoing routine surgery with an ileostomy were invited to participate in the study.
24 2013 Medical Oncology In-Training Examination (MedOnc ITE) were invited to participate in an optional postexamination su
25 Children in stable follow-up for more than 6 months post-LT were invited to participate in a case control study.
27 (20% women, 80% men) and 105 trainees (28% women, 72% men) were invited to participate, 48 participants were required to
31 pectant fathers who registered with their pregnant partners were invited to participate in this study.
32 ter completion of the trial, enrolling centers and patients were invited to participate in the FREEDOM Follow-On study.
33 tients treated for clefts in Norway during the study period were invited to participate (n = 2860).
34 lking and randomly selected from three UK family practices, were invited to participate in a parallel two-arm cluster ran
35 All patients on the clinic list for those practitioners were invited to participate and 107 were consented and observ
37 he parent study (GPS1) during the first year of recruitment were invited to participate in GPS2 and GPS3, which took plac
38 munosuppressive treatment such as infliximab and rituximab, were invited to participate in the study when they attended t
40 erts, identified through membership in the Orbital Society, were invited to participate in on online survey and they scor
41 ogram performing and/or evaluating VCA in the United States were invited to participate in a working group to assess the